PROM1 and neoplasm: An inspiring study found that in CD133+ self‐renewing tumor‐initiating cells, NOX1 was phosphorylated and activated by STAT3, and subsequent ROS overload stimulated the PI3K/AKT pathway, which increased the self‐renewal activity and tumorigenicity of CD133+ thyroid cells.330